Evidence map›Paper›PMID 28332008›Full record

ArticleDocumenta ophthalmologica. Advances in ophthalmology2017

Case of adult-onset neuronal intranuclear hyaline inclusion disease with negative electroretinogram.

Wataru Yamada, Akira Takekoshi, Kyoko Ishida, Kiyofumi Mochizuki, Jun Sone, Gen Sobue, Yuichi Hayashi, Takashi Inuzuka, Yozo Miyake

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Documenta ophthalmologica. Advances in ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuronal intranuclear inclusion disease in one family: clinical diversity and diagnostic challenges.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Characteristics of ocular findings of patients with neuronal intranuclear inclusion disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Recent progress in neuronal intranuclear inclusion disease: a review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Wataru YamadaDepartment of Ophthalmology, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu-shi, Gifu, 501-1194, Japan.
Akira TakekoshiDepartment of Neurology and Geriatrics, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu-shi, Gifu, 501-1194, Japan.
Kyoko IshidaDepartment of Ophthalmology, Toho University Ohashi Medical Center, 2-17-6, Ohashi, Muguro-ku, Tokyo, 153-0004, Japan.
Kiyofumi MochizukiDepartment of Ophthalmology, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu-shi, Gifu, 501-1194, Japan. mochi-gif@umin.ac.jp.
Jun SoneDepartment of Neurology, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, Shouwa-ku, Nagoya-shi, Aichi, 466-8560, Japan.
Gen SobueBrain and Mind Research Center, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, Shouwa-ku, Nagoya-shi, Aichi, 466-8560, Japan.
Yuichi HayashiDepartment of Neurology and Geriatrics, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu-shi, Gifu, 501-1194, Japan.
Takashi InuzukaDepartment of Neurology and Geriatrics, Gifu University Graduate School of Medicine, 1-1, Yanagido, Gifu-shi, Gifu, 501-1194, Japan.
Yozo MiyakeAichi Medical University, 1-2, Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan.
Gifu University · JPNagoya University · JPAichi Medical University · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report the findings in a 72-year-old man with neuronal intranuclear hyaline inclusion disease (NIHID) with the negative-type electroretinogram (ERG) and without night blindness.

methodsStandard ophthalmological examinations including the medical history, measurements of the best-corrected visual acuity and intraocular pressures, slit-lamp biomicroscopy, ophthalmoscopy, spectral-domain optical coherence tomography, fundus autofluorescence, and perimetry were performed. In addition, neurological and electrophysiological examinations were performed.

resultsNIHID was confirmed by skin biopsy. The ophthalmologic examinations revealed sluggish pupillary reflexes without visual disturbances and retinal abnormalities. The amplitudes of the dark-adapted 0.01 ERG was absent, and light-adapted 3 ERG and light-adapted 30 Hz flicker ERG were reduced in amplitude and delayed in implicit time. The rod system was more severely affected than the cone system, indicating that NIHID is classified as one of rod-cone dysfunction syndrome. The dark-adapted 3 ERG consisted of a markedly reduced b-wave with larger a-wave (negative ERG), but the amplitude of a-wave was smaller than normal.

conclusionsSince the ophthalmoscopical findings and the subjective visual functions may be essentially normal, the characteristic ERG abnormalities can be an important findings in adult-onset NIHID without night blindness.

Indexed as

ElectroretinographyAgedAge of OnsetDark AdaptationHumansIntranuclear Inclusion BodiesMaleNeurodegenerative DiseasesRetinal DiseasesVision DisordersAbnormal pupillary functionDementiaNegative ERGNeuronal intranuclear hyaline inclusion diseaseRod-cone dysfunction

Identifiers

PMID28332008
OpenAlexW2603413176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.